From the Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China (Z. Chen, Jia, T. Chen, Shen, Wang, Sun, Jiang); NHC Key Laboratory of Myopia, Fudan University; Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China (Z. Chen, Jia, T. Chen, Shen, Wang, Sun, Jiang); Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, China (Z. Chen, Jia, T. Chen, Shen, Wang, Sun, Jiang).
J Cataract Refract Surg. 2024 Jul 1;50(7):698-706. doi: 10.1097/j.jcrs.0000000000001434.
To evaluate the safety and efficacy of capsular tension ring and capsular hook (CTR-CH) implantation in Marfan syndrome (MFS) patients with ectopia lentis (EL).
Eye and ENT Hospital of Fudan University, Shanghai, China.
Retrospective propensity score-matched cohort study.
This study included patients with MFS who had in-the-bag intraocular lens (IOL) implantation assisted by CTR-CH or modified CTR (MCTR). The safety analysis focused on the resurgery rate. The efficacy analysis compared the corrected distance visual acuity (CDVA) and the incidence of laser capsulotomy after propensity score matching (PSM).
This study encompassed 148 eyes that had the CTR-CH procedure and 162 eyes that received MCTR implantation. In the CTR-CH group, the median age at the time of surgery was 5 years, with a mean follow-up duration of 1.81 ± 0.4 years. 5 eyes (3.38%) required a second surgery because of retinal detachment (2, 1.35%), IOL decentration (2, 1.35%), and CH dislocation (1, 0.68%). The resurgery rate was comparable with that of the MCTR group ( P = .486). After PSM, a total of 108 eyes were recruited in each group. Postoperative CDVA was significantly improved in both groups (both P < .001), but comparable between the groups ( P = .057). The posterior capsular opacification took place earlier ( P = .046) while the anterior capsular opacification required laser capsulotomy at a later stage ( P = .037) compared with the MCTR group.
The CTR-CH procedure was a feasible, safe, and efficient approach for managing EL in patients with MFS.
评估在马凡综合征(MFS)伴晶状体异位(EL)患者中植入囊袋张力环和囊袋钩(CTR-CH)的安全性和有效性。
中国上海复旦大学眼耳鼻喉科医院。
回顾性倾向评分匹配队列研究。
本研究纳入了接受 CTR-CH 或改良 CTR(MCTR)辅助下囊袋内人工晶状体(IOL)植入术的 MFS 患者。安全性分析主要关注再手术率,疗效分析比较了经倾向评分匹配(PSM)后的矫正视力(CDVA)和激光后囊切开术的发生率。
本研究共纳入 148 只眼行 CTR-CH 术,162 只眼行 MCTR 植入术。在 CTR-CH 组中,手术时的中位年龄为 5 岁,平均随访时间为 1.81±0.4 年。5 只眼(3.38%)因视网膜脱离(2 只眼,1.35%)、IOL 偏心(2 只眼,1.35%)和 CH 脱位(1 只眼,0.68%)需要二次手术。再手术率与 MCTR 组相当(P=0.486)。PSM 后,每组共纳入 108 只眼。两组术后 CDVA 均显著提高(均 P<0.001),但两组间无差异(P=0.057)。后囊混浊发生较早(P=0.046),而前囊混浊需激光后囊切开术的时间较晚(P=0.037)。
CTR-CH 术是治疗 MFS 伴 EL 患者的一种可行、安全且有效的方法。